Your browser doesn't support javascript.
loading
GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.
Brozek, Jan L; Canelo-Aybar, Carlos; Akl, Elie A; Bowen, James M; Bucher, John; Chiu, Weihsueh A; Cronin, Mark; Djulbegovic, Benjamin; Falavigna, Maicon; Guyatt, Gordon H; Gordon, Ami A; Hilton Boon, Michele; Hutubessy, Raymond C W; Joore, Manuela A; Katikireddi, Vittal; LaKind, Judy; Langendam, Miranda; Manja, Veena; Magnuson, Kristen; Mathioudakis, Alexander G; Meerpohl, Joerg; Mertz, Dominik; Mezencev, Roman; Morgan, Rebecca; Morgano, Gian Paolo; Mustafa, Reem; O'Flaherty, Martin; Patlewicz, Grace; Riva, John J; Posso, Margarita; Rooney, Andrew; Schlosser, Paul M; Schwartz, Lisa; Shemilt, Ian; Tarride, Jean-Eric; Thayer, Kristina A; Tsaioun, Katya; Vale, Luke; Wambaugh, John; Wignall, Jessica; Williams, Ashley; Xie, Feng; Zhang, Yuan; Schünemann, Holger J.
Affiliation
  • Brozek JL; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster GRADE Centre & Michael DeGroote Cochrane Canada Centre, McMaster University, Hamilton, Ontario, Canada.
  • Canelo-Aybar C; Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine, and Public Health. PhD Programme in Methodology of Biomedical Research and Public Health. Universitat Autònoma de Barcelona, Bellaterra, Spain; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBER
  • Akl EA; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
  • Bowen JM; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, Ontario, Canada.
  • Bucher J; National Toxicology Program, National Institute of Environmental Health Sciences, Durham, NC, USA.
  • Chiu WA; Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA.
  • Cronin M; School of Pharmacy and Chemistry, Liverpool John Moores University, Liverpool, UK.
  • Djulbegovic B; Center for Evidence-Based Medicine and Health Outcome Research, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Falavigna M; Institute for Education and Research, Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil.
  • Guyatt GH; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster GRADE Centre & Michael DeGroote Cochrane Canada Centre, McMaster University, Hamilton, Ontario, Canada.
  • Gordon AA; ICF International, Durham, NC, USA.
  • Hilton Boon M; Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Hutubessy RCW; Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Joore MA; Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Katikireddi V; Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • LaKind J; LaKind Associates, LLC, Catonsville, MD, USA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Langendam M; Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Manja V; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Surgery, University of California Davis, Sacramento, CA, USA; Department of Medicine, Department of Veterans Affairs, Northern California Health Care System, Mather, CA, USA.
  • Magnuson K; ICF International, Durham, NC, USA.
  • Mathioudakis AG; Division of Infection, Immunity and Respiratory Medicine, University Hospital of South Manchester, University of Manchester, Manchester, UK.
  • Meerpohl J; Institute for Evidence in Medicine, Medical Center, University of Freiburg, Freiburg-am-Breisgau, Germany; Cochrane Germany, Freiburg-am-Breisgau, Germany.
  • Mertz D; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Mezencev R; National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, USA.
  • Morgan R; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Morgano GP; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; McMaster GRADE Centre & Michael DeGroote Cochrane Canada Centre, McMaster University, Hamilton, Ontario, Canada.
  • Mustafa R; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • O'Flaherty M; Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.
  • Patlewicz G; National Center for Computational Toxicology, U.S. Environmental Protection Agency, Durham, NC, USA.
  • Riva JJ; McMaster GRADE Centre & Michael DeGroote Cochrane Canada Centre, McMaster University, Hamilton, Ontario, Canada; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Posso M; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.
  • Rooney A; National Toxicology Program, National Institute of Environmental Health Sciences, Durham, NC, USA.
  • Schlosser PM; National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, USA.
  • Schwartz L; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Shemilt I; EPPI-Centre, Institute of Education, University College London, London, UK.
  • Tarride JE; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Programs for Assessment of Technology in Health, McMaster University, Hamilton, Ontario, Canada.
  • Thayer KA; Department of Medicine, Department of Veterans Affairs, Northern California Health Care System, Mather, CA, USA.
  • Tsaioun K; Evidence-Based Toxicology Collaboration, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Vale L; Health Economics Group, Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
  • Wambaugh J; National Center for Computational Toxicology, U.S. Environmental Protection Agency, Durham, NC, USA.
  • Wignall J; ICF International, Durham, NC, USA.
  • Williams A; ICF International, Durham, NC, USA.
  • Xie F; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Zhang Y; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Health Quality Ontario, Toronto, Ontario, Canada.
  • Schünemann HJ; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; McMaster GRADE Centre & Michael DeGroote Cochrane Canada Centre, McMaster University, Hamilton, Ontario, Canada.
J Clin Epidemiol ; 129: 138-150, 2021 01.
Article in En | MEDLINE | ID: mdl-32980429

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: GRADE Approach / Systematic Reviews as Topic Type of study: Guideline / Health_technology_assessment / Overview / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: J Clin Epidemiol Journal subject: EPIDEMIOLOGIA Year: 2021 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: GRADE Approach / Systematic Reviews as Topic Type of study: Guideline / Health_technology_assessment / Overview / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: J Clin Epidemiol Journal subject: EPIDEMIOLOGIA Year: 2021 Document type: Article Affiliation country: Canada Country of publication: United States